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PERSPECTIVE

rationing lung transplants

Rationing Lung Transplants — Procedural Fairness
in Allocation and Appeals
Keren Ladin, Ph.D., and Douglas W. Hanto, M.D., Ph.D.

O

rgan transplantation requires
explicit rationing and relies
on public trust and altruism to
sustain the organ supply. The
well-publicized cases of two pediatric candidates for lung transplants have shaken the transplant community with emergency
legal injunctions arguing that
current lung-allocation policy is
“arbitrary and capricious.” Although the resulting transplantation seemingly provided an uplifting conclusion to an emotional
public debate, this precedent may
open the floodgates to litigation
from patients seeking to improve
their chances of obtaining organs. These cases questioned the
potential disadvantaging of children and the procedural fairness
in lung allocation. But legal appeals exacerbate inequities and
undercut public trust in the organ-transplantation system.
The controversy began when
the parents of Sarah Murnaghan,
a critically ill 10-year-old awaiting
a lung transplant for cystic fibrosis, appealed through her physicians to the Organ Procurement
and Transplantation Network
(OPTN) for an exception to the
policy that restricts lung-transplant candidates younger than
12 years to receiving organs from
donors younger than 12. When
this appeal failed, the Murnaghans
appealed to the media, politicians,
and finally a federal judge to grant
access to the larger pool of lungs
from adult donors. They argued
that mistreatment of pediatric
candidates for transplants would
probably result in Sarah’s death.
The merits of the case were never

argued, since during the 10-day
temporary injunction, Murnaghan
received two lung transplants
from adult donors. She has had
serious complications, including
pneumonia, and required a tracheostomy.
In 2005, to improve equity and
efficiency, the OPTN switched
from prioritization based on waiting time, a first-come–first-served
approach that often prioritized
less-urgent cases for organs, to
an approach that incorporated
consideration of urgency. After a
5-year review, the OPTN had developed a lung allocation score
(LAS) using medical factors that
predict disease severity and the
likelihood of dying on the waiting list.1 Such scores were assigned only to patients 12 or older,
because there were insufficient
data to support their applicability to younger populations, owing
to their different diagnoses and
limited outcomes data. Thus, patients younger than 12 were excluded from consideration for adolescent and adult donors’ lungs
(which are allocated according to
the LAS and geography) and limited to use of pediatric donors’
lungs, which are allocated according to two priority levels (different degrees of urgency based on
medical criteria) and geography.
The LAS policy has increased
lung-transplantation rates and
reduced mortality on the waiting list among older patients.2
Pediatric patients, however, continue to have higher waiting-list
mortality and are less likely to
receive transplants (see graphs),
despite wider geographic shar-
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ing of pediatric organs and the
use of urgency levels — primarily because there are few pediatric donors. The supporters of
the “under-12 rule” argue that it
promotes equity and efficiency
because of its aggregate benefits. They also cite the problematic discrepancy in lung size between adult donors and pediatric
recipients. Furthermore, as a
treatment for cystic fibrosis (the
most common diagnosis among
pediatric candidates for lung
transplants), transplantation has
been shown in several retrospective studies to have only marginal benefit, owing to improvements in medical management
(although some data suggest other
wise).3 Lung transplantation in
pediatric patients is also associated with high postoperative
morbidity and mortality, largely
because of the recipients’ underlying diagnoses.
Nevertheless, appeals to list
children for adult organs have
merit. First, designating age 12
as the cutoff arbitrarily disadvantages some children because
age is a poor proxy for size.
Younger patients who meet the
size requirements and could
benefit from adult lungs should
be considered eligible. Second,
in allocating other organs, we
often prioritize children, partly
on the basis of “fair innings”
considerations (equalizing people’s chances of living until a
given age) and partly because of
the unique importance for physical and cognitive development that
a transplant may confer. These
arguments also apply to lung
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Unadjusted Relative Risk of Dying While on the Waiting List or Becoming Too Sick to Receive a Lung Transplant (Panel A) and
Relative Likelihood of Receiving a Lung Transplant (Panel B), According to Age Group, September 12, 2010 to March 11, 2013.
The vertical lines represent 95% confidence intervals. Ages are patients’ maximum age at listing or their age at the start of the
period. Data are from the Lung Allocation Policy Review from the Executive Committee of the Organ Procurement and Transplantation Network–United Network for Organ Sharing, June 10, 2013.

transplantation. Third, transplanting lungs into children is similarly efficient to doing so in adults,
since their graft-survival rates are
similar. Lobar resection can facilitate transplantation of adult lungs
into smaller pediatric patients —
also with similar results.4 Finally,
given the scarcity of pediatric
lung transplants, the data necessary for optimal validation of the
LAS in this population may never
be available. Without conclusive
data, we should err on the side
of inclusion, not exclusion from
access to a broader supply of
lifesaving organs. Currently, only
30 children in the United States
await lung transplants, and only
11 of them are 6 to 11 years of
age. The change that would occur by allowing these children
access would most likely have
little effect on nonpediatric candidates.
In response to objections that
children are unfairly disadvantaged, the OPTN will review its
lung-allocation policy during the
600

next year and allow expedited appeals to an expert lung-allocation
board in the interim. Candidates
approved during this period will
gain access to the full pool of
lungs on the basis of the LAS and
geographic location, while maintaining their pediatric priority.
Are the organ-allocation and
appeals processes fair? Despite
this case, we believe they are. An
ethical framework that is gaining
traction in health policy, Accountability for Reasonableness (A4R),
offers an approach for achieving
fairness and legitimacy in allocating health resources.5 A4R
requires transparency about the
objectives of and evidence for decisions, consensus about the relevance of rationales used in resource allocation, a process for
reevaluating and revising criteria
in light of new evidence, and procedures for enforcing these conditions in the deliberative process.
This approach claims that a fair
deliberative process results in outcomes that are acceptable to all.
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A4R has limitations in Murnaghan’s case, including those
resulting from the limited data regarding lung-transplantation outcomes in the pediatric population.
But generally, organ allocation
follows A4R’s tenets: it is public,
transparent, revisable, enforceable, and open to appeals, and it
incorporates key stakeholders.
Organ-allocation algorithms seek
to balance equity and efficiency.
Committees comprising medical
and ethics experts, transplant recipients and donors, and other
key stakeholders meet in a predictable and transparent way.
They deliberate and issue reports
and policy recommendations that
are opened to public comment.
Policies are enforced and revised
regularly on the basis of new evidence.
Transplant candidates and their
families go to great lengths to
obtain lifesaving treatment. They
should be assured of fair process
and, in cases of error or newly
available information, allowed to
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appeal decisions. Appeals waged
through federal courts and the
court of public opinion, however,
undermine fairness. Judicial appeals grant discretionary access
to wealthier people, exacerbating
disparities and discrimination.
Moreover, appeals are inefficient,
complicating allocation and leading to longer allocation times,
poorer matches due to expansion
of criteria, and greater difficulty
in managing the waiting list.
Lawsuits also inappropriately saddle courts with decisions about
health policy. Finally, appeals reduce transparency and predictability, undermining the public perception of fairness, which could
reduce donation rates.
Although the OPTN’s allowance of appeals to an expert panel
is preferable to judicial appeals, it
is problematic. Relying on physicians to appeal on behalf of candidates leaves patients of lower
socioeconomic status, those less
informed about their options, and
those lacking advocates vulnerable to worse treatment. Physicians
may also fear that accepting the
responsibility of mounting ap-
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peals means assuming greater
risk of poor outcomes and subsequent audits, which may also result in disparities.
To prevent unequal treatment,
absent better data, we believe the
OPTN should expand its policy
to automatically assign an LAS to
pediatric candidates and put
those meeting the size and LAS
criteria for adult and adolescent
organs on the waiting list. Lung
transplants should be allocated
on the basis of the LAS and size
match, with consideration of lobar resection for small recipients
of adult lungs. Children should
retain preference for lungs from
pediatric donors.
Overall, we believe that the
organ-allocation process is fundamentally fair, in part because
of procedures in place to revise
and modify allocation. It is because of this fair process that errors can be discovered and addressed. Our proposed changes
would provide more lifesaving
lungs to children; they would
also provide useful data for the
1-year policy review and could
ensure equal treatment for all
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children awaiting lung transplants.
Disclosure forms provided by the authors
are available with the full text of this article
at NEJM.org.
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